Riccardo Carloni
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 2
-
- Cancer Genomics and Diagnostics 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Cancer Mechanisms and Therapy 3
-
- Gallbladder and Bile Duct Disorders 2
Riccardo Carloni
16 papers receiving 339 citations
Peers
Comparison fields: 5 of 58
- Hepatology 58
- Oncology 148
- Cancer Research 62
- General Dentistry 7
- Oral Surgery 24
Countries citing papers authored by Riccardo Carloni
This map shows the geographic impact of Riccardo Carloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riccardo Carloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riccardo Carloni more than expected).
Fields of papers citing papers by Riccardo Carloni
This network shows the impact of papers produced by Riccardo Carloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riccardo Carloni. The network helps show where Riccardo Carloni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Riccardo Carloni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2022 | 16 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 73 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 39 | |
| 11 | 2021 | 81 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 0 | |
| 17 | 2016 | 87 |
About Riccardo Carloni
Riccardo Carloni is a scholar working on Oncology, Hepatology and Cancer Research, having authored 17 papers that have together received 342 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers), Cancer Genomics and Diagnostics (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Hepatology (58 citations), Oncology (148 citations) and Cancer Research (62 citations). Riccardo Carloni has collaborated with scholars based in Italy, Türkiye and France. Frequent co-authors include Giovanni Brandi, Alessandro Rizzo, Alessandro Di Federico, Andrea De Giglio, Andrea Palloni, Mariacristina Di Marco, Giorgio Frega, Jean‐Paul Meningaud, Barbara Hersant and Thomas Wojcik. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.